{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-22-000294","form_type":"8-K","ticker":"GTHP","cik":"0000924515","company_name":"GUIDED THERAPEUTICS INC","filed_at":"2022-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.411080+00:00","generated_at":"2026-06-27T20:02:17.774885+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Guided Therapeutics approves 1-for-20 reverse stock split; FINRA effective date pending","bullets":["Board approved 1-for-20 reverse split on Dec 30, 2021; Certificate of Amendment filed with Delaware.","Each 20 shares reclassified into 1 share; no fractional shares issued, whole share granted instead.","Options, warrants, and convertible securities adjusted proportionally to reflect the split.","Stockholder approval obtained in July 2021; FINRA has not yet declared effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-22-000294","json":"https://secwatch.observer/filing/0001654954-22-000294.json","markdown":"https://secwatch.observer/filing/0001654954-22-000294.md","text":"https://secwatch.observer/filing/0001654954-22-000294.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/0001654954-22-000294-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/924515/000165495422000294/gthp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:02:17.774885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}